Product Description
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Austria | Brazil | Chile | Colombia | Croatia | Cyprus | Dominican Republic | Egypt | Germany | Hong Kong | Hungary | India | Ireland | Italy | Malaysia | Malta | New Zealand | Norway | Pakistan | Peru | South Africa | Spain | Taiwan | United Kingdom | United States | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
02/13/2019 |
News Article |
Global Small Animal Imaging Industry Growth on Account of the Rising Awareness and Advent of Technology by Market size, Share and Rising Trend |
